Aims and Scope of Oncology Reports
Oncology Reports is a peer-reviewed medical journal of oncology published monthly by Spandidos Publications. The editor-in-chief is Demetrios A. Spandidos. The journal was established in 1994.
Key Metrics
CiteScore 

7.6
Eigenfactor 

0.01 - 0.05
H-Index 

108
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

0.79
Recommended pre-submission checks
Powered by 

Topics Covered on Oncology Reports
Oncology Reports Journal Specifications
| Overview | |
| Publisher | SPANDIDOS PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Oncology Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Oncology Reports
Expression of Concern] Antitumor activity of Notch‑1 inhibition in human colorectal carcinoma cells.
- 1 Aug 2026
- Oncology reports
Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer.
- 1 Aug 2026
- Oncology reports
Sterol regulatory element‑binding proteins: Master regulators of lipid metabolic reprogramming in cancer and emerging therapeutic targets (Review).
- 1 Aug 2026
- Oncology reports
A fibroblast activation protein degrader enhances cisplatin sensitivity in non‑small cell lung cancer.
- 1 Aug 2026
- Oncology reports
Research advances on DKK1 in head and neck squamous cell carcinoma: Linking molecular mechanisms to clinical applications (Review).
- 1 Aug 2026
- Oncology reports
PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells.
- 1 Aug 2026
- Oncology reports
Expression of Concern] Antitumor activity of Notch‑1 inhibition in human colorectal carcinoma cells.
- 1 Aug 2026
- Oncology reports
Schisandrin B exhibits anti‑proliferative effects by inducing ferroptosis in pancreatic cancer.
- 1 Aug 2026
- Oncology reports
Sterol regulatory element‑binding proteins: Master regulators of lipid metabolic reprogramming in cancer and emerging therapeutic targets (Review).
- 1 Aug 2026
- Oncology reports
A fibroblast activation protein degrader enhances cisplatin sensitivity in non‑small cell lung cancer.
- 1 Aug 2026
- Oncology reports
Research advances on DKK1 in head and neck squamous cell carcinoma: Linking molecular mechanisms to clinical applications (Review).
- 1 Aug 2026
- Oncology reports
PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells.
- 1 Aug 2026
- Oncology reports